Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Fusco

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
Open Forum Infectious Diseases|August 12, 2021
Virologic Outcomes Among People Living With Human Immunodeficiency Virus With High Pretherapy Viral Load Burden Initiating on Common Core AgentsAnthony M Mills, Kathy L Schulman, Jennifer S Fusco, et al.
The Journal of Venomous Animals and Toxins Including Tropical Diseases|April 14, 2020
Biochemical characterization and cytotoxic effect of the skin secretion from the red-spotted Argentina frog <i>Argenteohyla siemersi</i> (Anura: Hylidae)Luciano S Fusco, Rodrigo Cajade, Jose M Piñeiro, et al.
AIDS Research and Human Retroviruses|March 14, 2024
Incident HIV-Associated Wasting/Low Weight Is Associated with Nearly Doubled Mortality Risk in the Modern ART EraMichael B Wohlfeiler, Rachel Palmieri Weber, Laurence Brunet, et al.
AIDS (London, England)|March 12, 2021
To dose-adjust or not to dose-adjust: lamivudine dose in kidney impairmentKaram Mounzer, Laurence Brunet, Christina M Wyatt, et al.
Infectious Diseases and Therapy|November 9, 2019
Virologic Outcomes Among ART-Naïve Individuals Initiating Dolutegravir, Elvitegravir, Raltegravir or Darunavir: An Observational StudyAnthony M Mills, Laurence Brunet, Jennifer S Fusco, et al.
AIDS Patient Care and Stds|October 5, 2021
Are We Hitting the Target? HIV Pre-Exposure Prophylaxis from 2012 to 2020 in the OPERA CohortKaram C Mounzer, Jennifer S Fusco, Ricky K Hsu, et al.
AIDS Research and Human Retroviruses|July 25, 2023
Definition, Burden, and Predictors of HIV-Associated Wasting and Low Weight in the OPERA CohortMichael B Wohlfeiler, Rachel Palmieri Weber, Laurence Brunet, et al.
International Journal of Biological Macromolecules|June 1, 2025
Venomic and F(ab')₂ antivenomic studies of Bothrops alternatus venom proteinsLuciano S Fusco, Emidio Beraldo-Neto, Juan J Calvete, et al.
The Journal of Nutrition, Health & Aging|June 9, 2016
Inappropriate Use of Proton Pump Inhibitors in Elderly Patients Discharged from Acute Care HospitalsR Schepisi, S Fusco, F Sganga, et al.
AIDS Research and Therapy|July 21, 2025
Characterizing treatment interruptions in the OPERA cohort and virologic outcomes after resumption with bictegravir/emtricitabine/tenofovir alafenamideKaram Mounzer, Michael D Osterman, Laurence Brunet, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
Open Forum Infectious Diseases|August 12, 2021
Virologic Outcomes Among People Living With Human Immunodeficiency Virus With High Pretherapy Viral Load Burden Initiating on Common Core AgentsAnthony M Mills, Kathy L Schulman, Jennifer S Fusco, et al.
The Journal of Venomous Animals and Toxins Including Tropical Diseases|April 14, 2020
Biochemical characterization and cytotoxic effect of the skin secretion from the red-spotted Argentina frog <i>Argenteohyla siemersi</i> (Anura: Hylidae)Luciano S Fusco, Rodrigo Cajade, Jose M Piñeiro, et al.
AIDS Research and Human Retroviruses|March 14, 2024
Incident HIV-Associated Wasting/Low Weight Is Associated with Nearly Doubled Mortality Risk in the Modern ART EraMichael B Wohlfeiler, Rachel Palmieri Weber, Laurence Brunet, et al.
AIDS (London, England)|March 12, 2021
To dose-adjust or not to dose-adjust: lamivudine dose in kidney impairmentKaram Mounzer, Laurence Brunet, Christina M Wyatt, et al.
Infectious Diseases and Therapy|November 9, 2019
Virologic Outcomes Among ART-Naïve Individuals Initiating Dolutegravir, Elvitegravir, Raltegravir or Darunavir: An Observational StudyAnthony M Mills, Laurence Brunet, Jennifer S Fusco, et al.
AIDS Patient Care and Stds|October 5, 2021
Are We Hitting the Target? HIV Pre-Exposure Prophylaxis from 2012 to 2020 in the OPERA CohortKaram C Mounzer, Jennifer S Fusco, Ricky K Hsu, et al.
AIDS Research and Human Retroviruses|July 25, 2023
Definition, Burden, and Predictors of HIV-Associated Wasting and Low Weight in the OPERA CohortMichael B Wohlfeiler, Rachel Palmieri Weber, Laurence Brunet, et al.
International Journal of Biological Macromolecules|June 1, 2025
Venomic and F(ab')₂ antivenomic studies of Bothrops alternatus venom proteinsLuciano S Fusco, Emidio Beraldo-Neto, Juan J Calvete, et al.
The Journal of Nutrition, Health & Aging|June 9, 2016
Inappropriate Use of Proton Pump Inhibitors in Elderly Patients Discharged from Acute Care HospitalsR Schepisi, S Fusco, F Sganga, et al.
AIDS Research and Therapy|July 21, 2025
Characterizing treatment interruptions in the OPERA cohort and virologic outcomes after resumption with bictegravir/emtricitabine/tenofovir alafenamideKaram Mounzer, Michael D Osterman, Laurence Brunet, et al.
Pageof 8